BACKGROUND: Adverse events and complications have been reported after sacral neurostimulation for @entity1241 , which may result in surgical revision and device explantation. Lead reimplantation may be feasible; however, available data regarding outcomes are less robust. OBJECTIVE: The aim of this study was to determine the outcomes of sacral neurostimulation lead reimplantation for @entity1241 . DESIGN: This was a retrospective review of prospectively collected data. SETTINGS: The study was conducted at 2 clinical sites from a single institution. @entity1 : @entity1 with @entity1241 who underwent sacral neurostimulation implantation or reimplantation between 2011 and 2014 were included in the study. INTERVENTIONS: Sacral neurostimulation reimplantation was the included intervention. MAIN OUTCOME MEASURES: Change in the Cleveland Clinic Florida @entity1241 Score (0 best; 20 worst) in reimplantation as compared with index implantation controls was the main measure. Secondary outcomes included the frequency and type of adverse events and complications. RESULTS: A total of 112 @entity1 underwent either sacral neurostimulation implantation or reimplantation between 2011 and 2014. Ninety-seven @entity1 underwent an index percutaneous nerve stimulation trial, 93 of whom also underwent a stimulator implantation. Fifteen @entity1 underwent lead reimplantation, with 5 performed before stimulator implantation and 10 after stimulator implantation. The index implanted and reimplanted groups had similar demographics, comorbidities, and complication profiles including explantation rates. The most common reason for reimplantation was lead related (6/15), including 4 lead migrations, 1 lead @entity174 , and 1 lead erosion. Significant decreases in the @entity322 score were achieved in each group (index implantation: p < 0.001; reimplantation: p = 0.006). When comparing the efficacy of sacral neurostimulation therapy in decreasing the @entity1241 score from baseline in each group, @entity1 with an index implantation were found to have a more significant improvement in their @entity322 score as compared with the reimplantation group (p = 0.047). LIMITATIONS: This was a retrospective study. A large number of @entity1 with incomplete functional assessment data were excluded from analysis. CONCLUSIONS: The improvements in @entity1241 are significantly better after index implantation than after reimplantation.

Outcomes of Sacral Neurostimulation Lead Reimplantation for XXXX : A Cohort Study.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients', 'PATIENTS'] @entity1241 :: ('MESH:D005242', 'Disease') :: ['Fecal Incontinence', 'fecal incontinence'] @entity322 :: ('MESH:D014549', 'Disease') :: ['incontinence'] @entity174 :: ('MESH:D050723', 'Disease') :: ['fracture']
@entity1241 :: (MESH:D005242,Disease) :: ['Fecal Incontinence']
